Literature DB >> 22043389

Food-drug interactions.

Rabia Bushra, Nousheen Aslam, Arshad Yar Khan.   

Abstract

The effect of drug on a person may be different than expected because that drug interacts with another drug the person is taking (drug-drug interaction), food, beverages, dietary supplements the person is consuming (drug-nutrient/food interaction) or another disease the person has (drug-disease interaction). A drug interaction is a situation in which a substance affects the activity of a drug, i.e. the effects are increased or decreased, or they produce a new effect that neither produces on its own. These interactions may occur out of accidental misuse or due to lack of knowledge about the active ingredients involved in the relevant substances. Regarding food-drug interactions physicians and pharmacists recognize that some foods and drugs, when taken simultaneously, can alter the body's ability to utilize a particular food or drug, or cause serious side effects. Clinically significant drug interactions, which pose potential harm to the patient, may result from changes in pharmaceutical, pharmacokinetic, or pharmacodynamic properties. Some may be taken advantage of, to the benefit of patients, but more commonly drug interactions result in adverse drug events. Therefore it is advisable for patients to follow the physician and doctors instructions to obtain maximum benefits with least food-drug interactions. The literature survey was conducted by extracting data from different review and original articles on general or specific drug interactions with food. This review gives information about various interactions between different foods and drugs and will help physicians and pharmacists prescribe drugs cautiously with only suitable food supplement to get maximum benefit for the patient.

Entities:  

Keywords:  Chelation; Cytochrome P450; Drug; Food-drug interaction

Year:  2011        PMID: 22043389      PMCID: PMC3191675          DOI: 10.5001/omj.2011.21

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  59 in total

1.  Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids.

Authors:  M Zhu; D E Nix; R D Adam; J M Childs; C A Peloquin
Journal:  Pharmacotherapy       Date:  2001-08       Impact factor: 4.705

Review 2.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Interaction between warfarin and cranberry juice.

Authors:  Jonathan L Aston; Amy E Lodolce; Nancy L Shapiro
Journal:  Pharmacotherapy       Date:  2006-09       Impact factor: 4.705

4.  Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.

Authors:  Andreas Serra; Dominik E Uehlinger; Paolo Ferrari; Bernhard Dick; Brigitte M Frey; Felix J Frey; Bruno Vogt
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

Review 5.  Drug interactions and consequences of sodium restriction.

Authors:  W M Bennett
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

6.  Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin.

Authors:  A P Griffiths; A Beddall; S Pegler
Journal:  J R Soc Promot Health       Date:  2008-11

7.  In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.

Authors:  Fa Ge; Fanli Zeng; Siguo Liu; Na Guo; Haiqing Ye; Yu Song; Junwen Fan; Xiuping Wu; Xuelin Wang; Xuming Deng; Qi Jin; Lu Yu
Journal:  J Med Microbiol       Date:  2010-01-14       Impact factor: 2.472

Review 8.  [Hypertension due to liquorice and liquorice tea consumption].

Authors:  H Boganen; K van Hee; H G L M Grundmeijer
Journal:  Ned Tijdschr Geneeskd       Date:  2007-12-22

Review 9.  [Oral thyroxine treatment: towards an individually tailored dose].

Authors:  Marco Centanni; Antonella Franchi; Maria Giulia Santaguida; Camilla Virili; Serena Nardo; Lucilla Gargano
Journal:  Recenti Prog Med       Date:  2007-09

Review 10.  Monoamine oxidase inhibitors. A perspective on their use in the elderly.

Authors:  H P Volz; C H Gleiter
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 4.271

View more
  38 in total

1.  In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.

Authors:  Klara Lalouckova; Eva Skrivanova; Johana Rondevaldova; Adela Frankova; Josef Soukup; Ladislav Kokoska
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

2.  Acute myocardial infarction after switching from warfarin to dabigatran.

Authors:  Wael Abuzeid; Hatim Al-Lawati; Neil Fam
Journal:  Oman Med J       Date:  2015-01

Review 3.  Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification: a review.

Authors:  Margueritta S El Asmar; Joseph J Naoum; Elias J Arbid
Journal:  Oman Med J       Date:  2014-05

4.  Oral administration of azithromycin ameliorates trypanosomosis in Trypanosoma congolense-infected mice.

Authors:  Nthatisi Innocentia Molefe; Shino Yamasaki; Adrian Miki C Macalanda; Keisuke Suganuma; Kenichi Watanabe; Xuenan Xuan; Noboru Inoue
Journal:  Parasitol Res       Date:  2017-07-04       Impact factor: 2.289

5.  Development of a Physiologically Based Pharmacokinetic Model for Prediction of Ethanol Concentration-Time Profile in Different Organs.

Authors:  Armin Sadighi; Lorenzo Leggio; Fatemeh Akhlaghi
Journal:  Alcohol Alcohol       Date:  2021-06-29       Impact factor: 2.826

6.  A Questionnaire-Based Survey to Assess the Level of Knowledge and Awareness about Drug-Food Interactions among General Public in Western Saudi Arabia.

Authors:  Syed Faisal Zaidi; Rayan Mgarry; Abdullah Alsanea; Sakar Khalid Almutairi; Yaser Alsinnari; Saad Alsobaei; Kanwal Ahmed
Journal:  Pharmacy (Basel)       Date:  2021-04-08

7.  Comparative outcome analysis of home-initiated non-medical interventions among toddlers with orally ingested substances.

Authors:  Menyfah Q Alanazi; Majed I Al-Jeraisy; Mahmoud Salam
Journal:  Ital J Pediatr       Date:  2015-09-15       Impact factor: 2.638

8.  Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report.

Authors:  Ajeet B Singh
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

9.  The Effects of Targeted Deliveries of Lovastatin and Tocotrienol on Ossification-Related Gene Expressions in Fracture Healing in an Osteoporosis Rat Model.

Authors:  Nurul 'Izzah Ibrahim; Norazlina Mohamed; Ima Nirwana Soelaiman; Ahmad Nazrun Shuid
Journal:  Int J Environ Res Public Health       Date:  2015-10-16       Impact factor: 3.390

10.  Drug interactions in dermatology: what the dermatologist should know.

Authors:  Arijit Coondoo; Chandan Chattopadhyay
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.